Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Early Attention To Marketing Can Make Or Break OTC Switches – Consultant

This article was originally published in The Tan Sheet

Executive Summary

Future Rx-to-OTC switches will be more complex and difficult than many past switches, but their success will continue to depend on a factor firms often overlook in the process, according to consultant Joe McGovern
Advertisement

Related Content

European OTC Industry Prescribes Key Role For Pharmacists
European OTC Industry Prescribes Key Role For Pharmacists
European OTC Industry Prescribes Key Role For Pharmacists
Sea Changes In Regulation And The Market: Top Stories Of 2008
Sea Changes In Regulation And The Market: Top Stories Of 2008
Sea Changes In Regulation And The Market: Top Stories Of 2008
FDA Advisors Say Greater Insight Needed On Self-Selection Of OTC Statins
Alli Marketing Stresses Education, With Emphasis On Minority Groups – GSK
Alli Marketing Stresses Education, With Emphasis On Minority Groups – GSK

Topics

Advertisement
UsernamePublicRestriction

Register

PS101586

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel